Literature DB >> 26542642

Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register-Based and Population-Based Cohort Study.

Katrine Hass Rubin1, Dorte Glintborg2, Mads Nybo3, Marianne Andersen2, Bo Abrahamsen1,4.   

Abstract

Hyperandrogenism, obesity, and hyperinsulinemia may protect against osteoporosis, whereas amenorrhea, increased cortisol, and low growth hormone may be associated with higher fracture risk in polycystic ovary syndrome (PCOS). The objective of this study was to investigate fracture risk in PCOS. In the PCOS Denmark study, women with PCOS and/or hirsutism were identified in the Danish National Patient Register (1995-2012). Each patient was assigned three age-matched controls on the index date of PCOS diagnosis. Individuals with a previous endocrine diagnosis were excluded. Within PCOS Denmark, we embedded a well-characterized subcohort of patients, PCOS OUH, diagnosed with PCOS at Odense University Hospital (n = 1217). We identified incident fractures by International Classification of Diseases, 10th Revision (ICD-10) codes and used conditional Cox regression analyses to compare fracture risk. In the PCOS Denmark study, there were 19,199 women with PCOS and 57,483 controls were included, mean age 30.6 years (range, 12-60 years). Fracture rates were decreased in PCOS Denmark (10.3/1000 patient years) versus controls (13.6/1000 patient years). The adjusted ORs were 0.76 (95% CI, 0.71 to 0.80) for all fractures, 0.82 (95% CI, 0.74 to 0.92) for major osteoporotic fractures, and 0.57 (95% CI, 0.47 to 0.70) for fractures of head and face. The risk reduction was more pronounced below the age of 30 years at diagnosis. Women with PCOS had significant more hospital contacts due to strains and sprains. In the PCOS OUH subcohort, the risk reduction of fractures did not differ between PCOS women with elevated versus normal testosterone levels and the risk reduction was nominally smaller in overweight versus normal weight PCOS women. Women with PCOS had reduced risk of fractures, in particular of the appendicular skeleton. The risk reduction was greater in women with younger age at diagnosis suggesting that the skeletal effects of PCOS may be greater in women who have not yet reached peak bone mass. Reduced participation in sports activities was probably not the reason for the reduced risk of fractures.
© 2015 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research (ASBMR).

Entities:  

Keywords:  FRACTURE RISK; NATIONWIDE; HIRSUTISM; POLYCYSTIC OVARY SYNDROME; REGISTER-BASED

Mesh:

Year:  2015        PMID: 26542642     DOI: 10.1002/jbmr.2737

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  12 in total

1.  PCOS and bone fractures.

Authors:  Fabio V Comim; Melissa O Premaor
Journal:  J Bone Miner Metab       Date:  2018-01-25       Impact factor: 2.626

2.  Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study.

Authors:  Hsin-Yi Yang; Herng-Sheng Lee; Wan-Ting Huang; Ming-Jer Chen; Solomon Chih-Cheng Chen; Yueh-Han Hsu
Journal:  J Bone Miner Metab       Date:  2017-12-26       Impact factor: 2.626

3.  Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study.

Authors:  Maryam Kazemi; Brittany Y Jarrett; Stephen A Parry; Anna E Thalacker-Mercer; Kathleen M Hoeger; Steven D Spandorfer; Marla E Lujan
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

Review 4.  The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis.

Authors:  Hannah E Young; Wendy E Ward
Journal:  Reprod Sci       Date:  2020-09-10       Impact factor: 3.060

5.  (±)-Equol does not interact with genistein on estrogen-dependent breast tumor growth.

Authors:  Huaxin Song; Jennifer R Hughes; Russell T Turner; Urszula T Iwaniec; Daniel R Doerge; William G Helferich
Journal:  Food Chem Toxicol       Date:  2019-11-28       Impact factor: 6.023

6.  Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.

Authors:  Danielle E Robinson; M Sanni Ali; Victoria Y Strauss; Leena Elhussein; Bo Abrahamsen; Nigel K Arden; Yoav Ben-Shlomo; Fergus Caskey; Cyrus Cooper; Daniel Dedman; Antonella Delmestri; Andrew Judge; Muhammad Kassim Javaid; Daniel Prieto-Alhambra
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

7.  Competing Factors Link to Bone Health in Polycystic Ovary Syndrome: Chronic Low-Grade Inflammation Takes a Toll.

Authors:  Shirin Kalyan; Millan S Patel; Elaine Kingwell; Hélène C F Côté; Danmei Liu; Jerilynn C Prior
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

8.  Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.

Authors:  Dorte Glintborg; Katrine Hass Rubin; Mads Nybo; Bo Abrahamsen; Marianne Andersen
Journal:  Cardiovasc Diabetol       Date:  2018-03-08       Impact factor: 9.951

9.  Plasma sclerostin levels are associated with nutritional status and insulin resistance but not hormonal disturbances in women with polycystic ovary syndrome.

Authors:  Katarzyna Wyskida; Grzegorz Franik; Aleksander Jerzy Owczarek; Piotr Choręza; Piotr Kocełak; Paweł Madej; Jerzy Chudek; Magdalena Olszanecka-Glinianowicz
Journal:  Arch Gynecol Obstet       Date:  2020-06-26       Impact factor: 2.344

10.  Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study.

Authors:  Dorte Glintborg; Katrine Hass Rubin; Mads Nybo; Bo Abrahamsen; Marianne Andersen
Journal:  Endocr Connect       Date:  2019-10-01       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.